188 related articles for article (PubMed ID: 31143508)
1. Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody.
Dao T; Mun SS; Scott AC; Jarvis CA; Korontsvit T; Yang Z; Liu L; Klatt MG; Guerreiro M; Selvakumar A; Brea EJ; Oh C; Liu C; Scheinberg DA
Oncoimmunology; 2019; 8(7):1570778. PubMed ID: 31143508
[TBL] [Abstract][Full Text] [Related]
2. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
3. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Sugiyama D; Nishikawa H; Maeda Y; Nishioka M; Tanemura A; Katayama I; Ezoe S; Kanakura Y; Sato E; Fukumori Y; Karbach J; Jäger E; Sakaguchi S
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17945-50. PubMed ID: 24127572
[TBL] [Abstract][Full Text] [Related]
4. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
5. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
6. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
8. A modified flow cytometry method for objective estimation of human CD4
Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
[TBL] [Abstract][Full Text] [Related]
9. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
10. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
11. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
12. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
Amarnath S; Dong L; Li J; Wu Y; Chen W
Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-targeted microbubble destruction-mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function.
Shi C; Zhang Y; Yang H; Dong T; Chen Y; Xu Y; Yang X; Liu P
Exp Ther Med; 2018 Jan; 15(1):31-38. PubMed ID: 29387180
[TBL] [Abstract][Full Text] [Related]
14. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.
Yuan XL; Chen L; Zhang TT; Ma YH; Zhou YL; Zhao Y; Wang WW; Dong P; Yu L; Zhang YY; Shen LS
World J Gastroenterol; 2011 Apr; 17(15):2019-27. PubMed ID: 21528082
[TBL] [Abstract][Full Text] [Related]
16. Expression of IL-7 receptor in human peripheral regulatory T cells.
Ciebiada M; Kasztalska K; Gorska-Ciebiada M; Barylski M; Gorski P
Arch Med Sci; 2013 Jun; 9(3):555-60. PubMed ID: 23847682
[TBL] [Abstract][Full Text] [Related]
17. Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.
Yu Y; Miller J; Leventhal JR; Tambur AR; Chandrasekaran D; Levitsky J; Luo X; Mathew JM
PLoS One; 2011; 6(7):e22450. PubMed ID: 21799858
[TBL] [Abstract][Full Text] [Related]
18. CD25-targeted antibody-drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity.
Zammarchi F; Havenith K; Bertelli F; Vijayakrishnan B; Chivers S; van Berkel PH
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912922
[TBL] [Abstract][Full Text] [Related]
19. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
Huang K; Ge S
Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
[TBL] [Abstract][Full Text] [Related]
20. Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25
Wilkinson DS; Ghosh D; Nickle RA; Moorman CD; Mannie MD
Front Immunol; 2017; 8():1782. PubMed ID: 29312311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
